Company: STAA
Filing Date: 2025-10-24
Form Type: DFAN14A
Source: 0001213900-25-102242
Chunk: 3

Company: STAAR SURGICAL CO
Filing Date: 2025-10-24
Form: DFAN14A
Chunk 3
---
 been favorable to the deal.

It is time for STAAR to move past this ill-conceived transaction
and get back to the important work of operating and building the business. The adjournment of the vote prolongs the uncertainty surrounding
the Company and risks further disrupting STAAR’s momentum.

This Board clearly does not have a mandate to make any changes
to the proposed transaction or further delay the termination of the agreement. We call upon the Board to let shareholders vote.

Moreover, we continue to believe that shareholder confidence
in the Board can be restored only by removing directors. To that end, we intend to seek the removal of Board Chair Elizabeth Yeu, who
was a consultant to Alcon until very recently; CEO Stephen Farrell, who stands to make $24 million from the sale of STAAR after just five
months in his role; and the Board’s Compensation Committee Chair, Arthur Butcher, who approved egregious exit compensation packages
for executives in conjunction with the transaction. We intend to proceed with our efforts to call a Special Meeting to remove these directors.”

Broadwood encourages its fellow shareholders to review its materials
at www.LetSTAARShine.com,
and to vote on its GREEN Proxy Card “AGAINST” the proposed transaction.

About Broadwood

Broadwood Partners, L.P. is managed by Broadwood Capital, Inc. Broadwood
Capital is a private investment firm based in New York City. Neal C. Bradsher is the President of Broadwood Capital.

Certain Information Concerning the Participants

Broadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher,
Richard T. LeBuhn, Natalie R. Capasso, Raymond A. Myers and Jason J. Martin (collectively, the “Participants”) are participants
in the solicitation of proxies from the shareholders of STAAR in connection with the special meeting of shareholders scheduled for October
23, 2025 (including any adjournments, postponements, reschedulings or continuations thereof, the “Special Meeting”). The Participants
have filed a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”) and accompanying GREEN Proxy
Card to be used in connection with any such solicitation of proxies from the Company’s shareholders for the Special Meeting. SHAREHOLDERS OF STAAR ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS HAVE FILED OR WILL FILE WITH